Literature DB >> 25872329

Prevalence of endometriosis in epithelial ovarian cancer. Analysis of the associated clinical features and study on molecular mechanisms involved in the possible causality.

F Machado-Linde, M L Sánchez-Ferrer, P Cascales, A Torroba, R Orozco, Y Silva Sánchez, A Nieto, G Fiol.   

Abstract

PURPOSE OF INVESTIGATION: To determine the prevalence of endometriosis in patients with epithelial ovarian cancer and explore the differences between women with endometrioid and clear-cell histologic subtypes with and without associated endometriosis.
MATERIALS AND METHODS: The medical charts of 496 patients with epithelial ovarian cancer at the Hospital Virgin de la Arrixaca (Murcia, Spain) between 1971 and 2010 were reviewed.
RESULTS: Endometriosis was present in 27 (5.4%) of the 496 cases (p < 0001), and was associated with the endometrioid histotype in 13/45 cases (29%) and with the clear cell histotype in 7/22 (32%). The prevalence of an association with endometriosis according to histologic type was 28.8% (13/45) for endometrioid carcinoma and 31.8% (7/22) for clear-cell carcinoma.
CONCLUSION: Both endometrioid and clear-cell ovarians tumours are associated with pelvic endometriosis. Patients with endometiosis associated ovarian cancer differ from non-endometiosis associated ovarian cancer in their clinical characteristics.

Entities:  

Mesh:

Year:  2015        PMID: 25872329

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  7 in total

1.  Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer.

Authors:  Tze-Kiong Er; Yu-Fa Su; Chun-Chieh Wu; Chih-Chieh Chen; Jing Wang; Tsung-Hua Hsieh; Marta Herreros-Villanueva; Wan-Tzu Chen; Yi-Ting Chen; Ta-Chih Liu; Hung-Sheng Chen; Eing-Mei Tsai
Journal:  J Mol Med (Berl)       Date:  2016-02-27       Impact factor: 4.599

2.  Baicalein reduces endometriosis by suppressing the viability of human endometrial stromal cells through the nuclear factor-κB pathway in vitro.

Authors:  Zhixing Jin; Jianqin Huang; Zhiling Zhu
Journal:  Exp Ther Med       Date:  2017-08-01       Impact factor: 2.447

3.  Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer.

Authors:  Isabel Ñiguez Sevilla; Francisco Machado Linde; Maria Del Pilar Marín Sánchez; Julián Jesús Arense; Amparo Torroba; Anibal Nieto Díaz; Maria Luisa Sánchez Ferrer
Journal:  J Gynecol Oncol       Date:  2019-03-04       Impact factor: 4.401

Review 4.  Brassica Bioactives Could Ameliorate the Chronic Inflammatory Condition of Endometriosis.

Authors:  Paula García-Ibañez; Lucía Yepes-Molina; Antonio J Ruiz-Alcaraz; María Martínez-Esparza; Diego A Moreno; Micaela Carvajal; Pilar García-Peñarrubia
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

5.  Testosterone-Secreting Endometrioid Ovarian Carcinoma Presenting With Hyperandrogenism.

Authors:  Krishnakumar Rajamani; Richard G Moore; Sheena M Stanard; Olga Astapova
Journal:  AACE Clin Case Rep       Date:  2022-01-25

6.  Giant Ovarian Endometrioma: A Case Report.

Authors:  Anisah Yahya; Aisha Mustapha; Abimbola Omolara Kolawole; Adekunle Olarenwaju Oguntayo; Nafisa Bello; Halima Oziohu Aliyu; Sunday Adeyemi Adewuyi
Journal:  J West Afr Coll Surg       Date:  2022-07-29

Review 7.  The Endometriotic Tumor Microenvironment in Ovarian Cancer.

Authors:  Jillian R Hufgard Wendel; Xiyin Wang; Shannon M Hawkins
Journal:  Cancers (Basel)       Date:  2018-08-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.